Stryker (SYK) — Q2 2026 Earnings Preview
Key Factors to Watch for Q2 2026
| Factor | Details / What to Watch |
|---|---|
| Organic Sales Growth | Guidance: 8.0%–9.5% for FY26; Q1 was +2.4% due to cyber incident. Look for Q2 rebound and catch-up. |
| Adjusted EPS | Guidance: $14.90–$15.10 for FY26; Q1 was $2.60 (-8.5% YoY). Q2 should show sequential recovery. |
| Operating Margin | Guidance: +50 bps YoY for FY26; Q1 adjusted margin was 21.1% (-180 bps YoY). Margin recovery pace. |
| Capital Order Book/Backlog | Management continues to cite elevated backlog and strong CapEx demand—watch for confirmation of trends. |
| Mako Installations/Utilization | Record Q1 installations despite cyberattack; continued momentum and feedback on Mako 4 and RPS. |
| MedSurg & Neurotech Growth | Q1 organic growth +0.9% (vs. +12.6% in Q4 2025); expect normalization and acceleration in Q2/Q3. |
